Skip to main content
Fig. 9 | Chinese Medicine

Fig. 9

From: Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology

Fig. 9

a, b Identification and trends of potential biomarkers in rats. Figure a shows that guanidinosuccinic acid, 25-hydroxycholesterol, 5-hydroxyindolepyruvate and cAMP were potential biomarkers in the control group and pyrotinib model group. Figure b shows that 25-hydroxycholesterol, guanidinosuccinic acid, 5-hydroxyindolepyruvate, and cAMP were potential biomarkers in pyrotinib model group and SBP treatment group. C: control group; P: pyrotinib model group; SP: pyrotinib + SBP treatment group

Back to article page